Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

  • Dansk
  • NL
  • EN
  • FI
  • FR
  • DE
  • EL
  • IT
  • NO
  • PL
  • PT
  • RO
  • SL
  • ES
  • SV

Ombudsman launches investigation into European Commission’s Dalligate secrecy

The EU Ombudsman has launched an investigation into the European Commission's secrecy around 'Dalligate', the tobacco lobbying scandal that led to the forced resignation of health Commissioner John Dalli.

The investigation follows a complaint filed earlier this year by Corporate Europe Observatory (CEO), which accused the Commission of secrecy, selective release of documents and failure to fulfill its obligations under EU transparency legislation (Regulation 1049/2001). In its complaint to the Ombudsman CEO argued that "the Commission has unduly refused access to documents, failed to provide clarity about which documents falling under the scope of request actually exist and used delay tactics."

The Ombudsman has now asked European Commission President Barroso “to submit an opinion on the allegations”. The Ombudsman moreover wants to inspect the Commission's files relating to the resignation of Commissioner Dalli. CEO will receive a copy of the inspection report.

On 26 October 2012, CEO had requested access to “all documents related to Commissioner Dalli’s resignation over the issues covered in the OLAF investigation, including all minutes (and other notes) of meetings, all correspondence (including by email), both internal and external, and any other documents held by the Commission on these matters.” The Commission refused to disclose the most important of these documents.

Since Commissioner Dalli resigned under under controversial circumstances five months ago, the European Commission continues to refuse clarifying the basic facts about the scandal, leaving key questions from MEPs and civil society groups unanswered. The Ombudsman investigation might help to break the Commission's silence and clear the smoke around Commisisoner Dalli's resignation.

Attached files: 
The investigation follows a complaint filed earlier this year by Corporate Europe Observatory (CEO), which accused the Commission of secrecy, selective release of documents and failure to fulfill its obligations under EU transparency legislation (Regulation 1049/2001). In its complaint to the Ombudsman CEO argued that "the Commission has unduly refused access to documents, failed to provide clarity about which documents falling under the scope of request actually exist and used delay tactics."The Ombudsman has now asked European Commission President Barroso “to submit an opinion on the allegations”. The Ombudsman moreover wants to inspect the Commission's files relating to the resignation of Commissioner Dalli. CEO will receive a copy of the inspection report.On 26 October 2012, CEO had requested access to “all documents related to Commissioner Dalli’s resignation over the issues covered in the OLAF investigation, including all minutes (and other notes) of meetings, all correspondence (including by email), both internal and external, and any other documents held by the Commission on these matters.” The Commission refused to disclose the most important of these documents.Since Commissioner Dalli resigned under under controversial circumstances five months ago, the European Commission continues to refuse clarifying the basic facts about the scandal, leaving key questions from MEPs and civil society groups unanswered. The Ombudsman investigation might help to break the Commission's silence and clear the smoke around Commisisoner Dalli's resignation.
 

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

The European Commission proposal on scientific criteria defining endocrine disruptors (EDCs) is the latest dangerous outgrowth of a highly toxic debate. The chemical lobby, supported by certain Commission factions (notably DG SANTE and the Secretary-General) and some member states (UK and Germany), has put significant obstacles in the way of effective public health and environment regulation.

In the run up to the UK referendum on EU membership on 23 June, Corporate Europe Observatory has tabled a series of freedom of information requests to find out how UK finance lobbies have been influencing the referendum negotiations and the Capital Markets Union. But the Brexit-Bremain referendum seems to be a freedom of information black hole.

From the day a referendum on UK membership of the EU was first announced in 2013, the financial sector started using Cameron’s re-negotiation process to promote its deregulatory agenda. Sometimes lobbying was required, but more often the UK government did its work for them. 

A new report on carbon market reform has kicked off debate on the issue in the European Parliament. It promises new loopholes for the oil industry and other polluters.

Biodiversity collapse, the future of agriculture, politics versus science, EU States and the European Commission shifting blame on each other, industry's capture of the regulatory process through data secrecy, a Commissioner caught between Juncker, EU States, lobby groups, and his own services... The glyphosate saga, coming to an end this week with the European Commission's decision to extend its licence, has been an entry point into many broader problems. Overview.

The official EU assessment of glyphosate was based on unpublished studies owned by industry. Seven months later, the pesticide industry still fights disclosure and, so far, successfully. We obtained a copy of their arguments.

While CEO is not taking a position on the UK referendum, many of our publications are relevant to those who will have a vote, or those who are following the debate.

The current struggle in France over labour law reforms is not just between the Government and trade unions – a European battle is waged. The attacks on social rights stem in no small part from the web of EU-rules dubbed 'economic governance', invented to impose austerity policies on member states.

 
 
 
 
 
-- placeholder --
 
 
 

The corporate lobby tour